Indicator type;Branch of activity;Total
Number of companies carrying out R&D in Biotechnology;Total companies;1.376
Number of companies carrying out R&D in Biotechnology;Agriculture;98
Number of companies carrying out R&D in Biotechnology;Industry and Construction;407
Number of companies carrying out R&D in Biotechnology;Services;871
% Companies by type of biotechnology used: Genetic Code;Total companies;31,4
% Companies by type of biotechnology used: Genetic Code;Agriculture;19,4
% Companies by type of biotechnology used: Genetic Code;Industry and Construction;17,2
% Companies by type of biotechnology used: Genetic Code;Services;39,5
% Companies by type of biotechnology used: Functional Units;Total companies;43,7
% Companies by type of biotechnology used: Functional Units;Agriculture;28,8
% Companies by type of biotechnology used: Functional Units;Industry and Construction;40,3
% Companies by type of biotechnology used: Functional Units;Services;47
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Total companies;22,8
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Agriculture;14,6
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Industry and Construction;18,2
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Services;25,9
% Companies by type of biotechnology used: Bioprocesses;Total companies;48,3
% Companies by type of biotechnology used: Bioprocesses;Agriculture;40,3
% Companies by type of biotechnology used: Bioprocesses;Industry and Construction;74,5
% Companies by type of biotechnology used: Bioprocesses;Services;37
% Companies by type of biotechnology used: Subcellular Organisms;Total companies;7,9
% Companies by type of biotechnology used: Subcellular Organisms;Agriculture;5
% Companies by type of biotechnology used: Subcellular Organisms;Industry and Construction;4,9
% Companies by type of biotechnology used: Subcellular Organisms;Services;9,6
% Companies by type of biotechnology used: Bioinformatics;Total companies;27,1
% Companies by type of biotechnology used: Bioinformatics;Agriculture;11,9
% Companies by type of biotechnology used: Bioinformatics;Industry and Construction;13
% Companies by type of biotechnology used: Bioinformatics;Services;35,5
% Companies by type of biotechnology used: Nanobiotechnology;Total companies;11,2
% Companies by type of biotechnology used: Nanobiotechnology;Agriculture;1,1
% Companies by type of biotechnology used: Nanobiotechnology;Industry and Construction;7,2
% Companies by type of biotechnology used: Nanobiotechnology;Services;14,3
% Companies by type of biotechnology used: Other;Total companies;17,6
% Companies by type of biotechnology used: Other;Agriculture;30,3
% Companies by type of biotechnology used: Other;Industry and Construction;9,5
% Companies by type of biotechnology used: Other;Services;20
Companies in which biotechnology activities are: Main and/or exclusive;Total companies;711
Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;22
Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;112
Companies in which biotechnology activities are: Main and/or exclusive;Services;576
Companies in which biotechnology activities are: A secondary business line;Total companies;270
Companies in which biotechnology activities are: A secondary business line;Agriculture;22
Companies in which biotechnology activities are: A secondary business line;Industry and Construction;107
Companies in which biotechnology activities are: A secondary business line;Services;140
Companies in which biotechnology activities are: A necessary tool for production;Total companies;395
Companies in which biotechnology activities are: A necessary tool for production;Agriculture;53
Companies in which biotechnology activities are: A necessary tool for production;Industry and Construction;188
Companies in which biotechnology activities are: A necessary tool for production;Services;154
% Companies by final application areas of biotechnology use: Human Health;Total companies;48
% Companies by final application areas of biotechnology use: Human Health;Agriculture;1,2
% Companies by final application areas of biotechnology use: Human Health;Industry and Construction;25,1
% Companies by final application areas of biotechnology use: Human Health;Services;63,9
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Total companies;16,9
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Agriculture;27,6
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Industry and Construction;14
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Services;17
% Companies by final application areas of biotechnology use: Food Products;Total companies;29,4
% Companies by final application areas of biotechnology use: Food Products;Agriculture;26,9
% Companies by final application areas of biotechnology use: Food Products;Industry and Construction;48
% Companies by final application areas of biotechnology use: Food Products;Services;21
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Total companies;25,7
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Agriculture;69,5
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Industry and Construction;25,4
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Services;20,9
% Companies by final application areas of biotechnology use: Environment;Total companies;18
% Companies by final application areas of biotechnology use: Environment;Agriculture;12,4
% Companies by final application areas of biotechnology use: Environment;Industry and Construction;20,9
% Companies by final application areas of biotechnology use: Environment;Services;17,4
% Companies by final application areas of biotechnology use: Industry;Total companies;13
% Companies by final application areas of biotechnology use: Industry;Agriculture;5,5
% Companies by final application areas of biotechnology use: Industry;Industry and Construction;15,5
% Companies by final application areas of biotechnology use: Industry;Services;12,7
R&D personnel in Biotechnology (PP);Total companies;17.257
R&D personnel in Biotechnology (PP);Agriculture;1.029
R&D personnel in Biotechnology (PP);Industry and Construction;4.994
R&D personnel in Biotechnology (PP);Services;11.233
R&D personnel in Biotechnology (PP): Research personnel;Total companies;9.195
R&D personnel in Biotechnology (PP): Research personnel;Agriculture;265
R&D personnel in Biotechnology (PP): Research personnel;Industry and Construction;2.023
R&D personnel in Biotechnology (PP): Research personnel;Services;6.908
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Total companies;8.061
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Agriculture;764
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Industry and Construction;2.972
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Services;4.325
R&D personnel in Biotechnology (PP). Women;Total companies;9.980
R&D personnel in Biotechnology (PP). Women;Agriculture;441
R&D personnel in Biotechnology (PP). Women;Industry and Construction;2.831
R&D personnel in Biotechnology (PP). Women;Services;6.709
R&D personnel in Biotechnology (PP). Women: Research personnel;Total companies;5.222
R&D personnel in Biotechnology (PP). Women: Research personnel;Agriculture;109
R&D personnel in Biotechnology (PP). Women: Research personnel;Industry and Construction;1.139
R&D personnel in Biotechnology (PP). Women: Research personnel;Services;3.974
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Total companies;4.758
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Agriculture;332
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Industry and Construction;1.691
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Services;2.735
R&D personnel in Biotechnology (FTE);Total companies;12.883,4
R&D personnel in Biotechnology (FTE);Agriculture;700
R&D personnel in Biotechnology (FTE);Industry and Construction;3.623
R&D personnel in Biotechnology (FTE);Services;8.560,3
R&D personnel in Biotechnology (FTE): Research personnel;Total companies;7.103,2
R&D personnel in Biotechnology (FTE): Research personnel;Agriculture;191,6
R&D personnel in Biotechnology (FTE): Research personnel;Industry and Construction;1.552,1
R&D personnel in Biotechnology (FTE): Research personnel;Services;5.359,5
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Total companies;5.780,2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Agriculture;508,5
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;2.070,9
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Services;3.200,8
R&D personnel in Biotechnology (FTE). Women;Total companies;7.600,6
R&D personnel in Biotechnology (FTE). Women;Agriculture;304,9
R&D personnel in Biotechnology (FTE). Women;Industry and Construction;2.202,7
R&D personnel in Biotechnology (FTE). Women;Services;5.093
R&D personnel in Biotechnology (FTE). Women: Research personnel;Total companies;4.057
R&D personnel in Biotechnology (FTE). Women: Research personnel;Agriculture;85,2
R&D personnel in Biotechnology (FTE). Women: Research personnel;Industry and Construction;911,7
R&D personnel in Biotechnology (FTE). Women: Research personnel;Services;3.060,1
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Total companies;3.543,7
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;219,7
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1.291
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Services;2.032,9
Expenditure on internal R&D in Biotechnology (thousands of euros);Total companies;1.283.346
Expenditure on internal R&D in Biotechnology (thousands of euros);Agriculture;47.651
Expenditure on internal R&D in Biotechnology (thousands of euros);Industry and Construction;392.948
Expenditure on internal R&D in Biotechnology (thousands of euros);Services;842.746
1) By type of expenditure: Current expenditure;Total companies;1.180.187
1) By type of expenditure: Current expenditure;Agriculture;43.927
1) By type of expenditure: Current expenditure;Industry and Construction;367.183
1) By type of expenditure: Current expenditure;Services;769.077
1.1) Labour expenditure of research personnel;Total companies;372.421
1.1) Labour expenditure of research personnel;Agriculture;9.505
1.1) Labour expenditure of research personnel;Industry and Construction;106.176
1.1) Labour expenditure of research personnel;Services;256.740
1.2) Labour expenditure of technical and auxiliary personnel;Total companies;229.734
1.2) Labour expenditure of technical and auxiliary personnel;Agriculture;18.692
1.2) Labour expenditure of technical and auxiliary personnel;Industry and Construction;87.860
1.2) Labour expenditure of technical and auxiliary personnel;Services;123.182
1.3) Other current expenditure;Total companies;578.032
1.3) Other current expenditure;Agriculture;15.730
1.3) Other current expenditure;Industry and Construction;173.147
1.3) Other current expenditure;Services;389.155
2) By type of expenditure: Capital expenditure;Total companies;103.159
2) By type of expenditure: Capital expenditure;Agriculture;3.725
2) By type of expenditure: Capital expenditure;Industry and Construction;25.766
2) By type of expenditure: Capital expenditure;Services;73.669
2.1) Land and buildings;Total companies;10.889
2.1) Land and buildings;Agriculture;500
2.1) Land and buildings;Industry and Construction;1.158
2.1) Land and buildings;Services;9.231
2.2) Equipment and tools;Total companies;59.204
2.2) Equipment and tools;Agriculture;3.152
2.2) Equipment and tools;Industry and Construction;17.922
2.2) Equipment and tools;Services;38.130
2.3) Acquisition of specific R&D software;Total companies;5.623
2.3) Acquisition of specific R&D software;Agriculture;5
2.3) Acquisition of specific R&D software;Industry and Construction;879
2.3) Acquisition of specific R&D software;Services;4.739
2.4) Other R&D-specific IP products;Total companies;27.442
2.4) Other R&D-specific IP products;Agriculture;67
2.4) Other R&D-specific IP products;Industry and Construction;5.807
2.4) Other R&D-specific IP products;Services;21.569
1.1) By origin of funds: Own funds;Total companies;887.527
1.1) By origin of funds: Own funds;Agriculture;45.510
1.1) By origin of funds: Own funds;Industry and Construction;325.418
1.1) By origin of funds: Own funds;Services;516.599
1.2) By origin of funds: Funds from the Business sector;Total companies;143.903
1.2) By origin of funds: Funds from the Business sector;Agriculture;280
1.2) By origin of funds: Funds from the Business sector;Industry and Construction;3.861
1.2) By origin of funds: Funds from the Business sector;Services;139.762
1.3) By origin of funds: Funds from the Public Administration sector;Total companies;126.546
1.3) By origin of funds: Funds from the Public Administration sector;Agriculture;1.841
1.3) By origin of funds: Funds from the Public Administration sector;Industry and Construction;15.631
1.3) By origin of funds: Funds from the Public Administration sector;Services;109.074
1.4) By origin of funds: Funds from the Higher Education sector;Total companies;94
1.4) By origin of funds: Funds from the Higher Education sector;Agriculture;0
1.4) By origin of funds: Funds from the Higher Education sector;Industry and Construction;0
1.4) By origin of funds: Funds from the Higher Education sector;Services;94
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Total companies;12.623
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Agriculture;0
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Industry and Construction;47
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Services;12.576
1.6) By origin of funds: Funds from the rest of the world;Total companies;112.652
1.6) By origin of funds: Funds from the rest of the world;Agriculture;21
1.6) By origin of funds: Funds from the rest of the world;Industry and Construction;47.991
1.6) By origin of funds: Funds from the rest of the world;Services;64.641
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Total companies;137.432
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Agriculture;703
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Industry and Construction;68.573
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Services;68.156
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Total companies;88.127
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Agriculture;631
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Industry and Construction;59.264
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Services;28.231
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Total companies;49.305
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Agriculture;72
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Industry and Construction;9.309
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Services;39.924
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Total companies;43,7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Agriculture;36,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Industry and Construction;31,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Services;50,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Total companies;16,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Agriculture;18,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Industry and Construction;17,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Services;15,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Total companies;23,7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Agriculture;27,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Industry and Construction;24,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Services;22,9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Total companies;14,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Agriculture;13,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Industry and Construction;13,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Services;15,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Total companies;18,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Agriculture;13,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Industry and Construction;9,7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Services;22,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Total companies;19,6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Agriculture;14,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Industry and Construction;12,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Services;23,5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Total companies;19,1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Agriculture;19,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Industry and Construction;18,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Services;19,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Total companies;49,8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Agriculture;45,6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Industry and Construction;46,2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Services;52
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Total companies;59,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Agriculture;49,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Industry and Construction;53,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Services;63,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Total companies;22,3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Agriculture;19,4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Industry and Construction;18,9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Services;24,2
% Companies with international revenues related to biotechnology activities;Total companies;23,6
% Companies with international revenues related to biotechnology activities;Agriculture;8,7
% Companies with international revenues related to biotechnology activities;Industry and Construction;21,1
% Companies with international revenues related to biotechnology activities;Services;26,4
% Companies representing international revenues related to biotechnology activities;Total companies;1,5
% Companies representing international revenues related to biotechnology activities;Agriculture;0,5
% Companies representing international revenues related to biotechnology activities;Industry and Construction;1,3
% Companies representing international revenues related to biotechnology activities;Services;2,7
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Total companies;57,6
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Agriculture;58,1
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Industry and Construction;58,3
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Services;54,9
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Total companies;42,4
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Agriculture;41,9
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Industry and Construction;41,7
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Services;45,1
% International revenues related to biotechnology activities by classification: International trade in goods and services;Total companies;82,3
% International revenues related to biotechnology activities by classification: International trade in goods and services;Agriculture;64,5
% International revenues related to biotechnology activities by classification: International trade in goods and services;Industry and Construction;83,1
% International revenues related to biotechnology activities by classification: International trade in goods and services;Services;79,9
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total companies;14,1
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;35
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;15,6
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;7,9
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Total companies;1,5
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Agriculture;0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Industry and Construction;0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Services;7
% International revenues related to biotechnology activities by classification: Other;Total companies;2,1
% International revenues related to biotechnology activities by classification: Other;Agriculture;0,5
% International revenues related to biotechnology activities by classification: Other;Industry and Construction;1,2
% International revenues related to biotechnology activities by classification: Other;Services;5,2